TY  - JOUR
T1  - EFfect of physician payment disclosure laws on prescribing
AU  - Pham-Kanter G, Alexander G, Nair K
Y1  - 2012/05/28
N1  - 10.1001/archinternmed.2012.1210
JO  - Archives of Internal Medicine
SP  - 819
EP  - 821
VL  - 172
IS  - 10
N2  - 
With the enactment of the Physician Payments Sunshine Provision of the Affordable Care Act, pharmaceutical manufacturers are now required to disclose certain payments made to physicians—for example, payments for consulting, honoraria, gifts, or travel.1 This law is based on the premise that transparency in these transactions is of public importance and that disclosure acts as a deterrent against quid pro quo exchanges; physicians may be reluctant to accept large payments if these payments are publicly known and perceived as compensation for prescribing certain therapies.2- 3

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2012.1210
UR  - http://dx.doi.org/10.1001/archinternmed.2012.1210
ER  -